United States - English - NLM (National Library of Medicine)

cardinal health 107, llc - lansoprazole (unii: 0k5c5t2qpg) (lansoprazole - unii:0k5c5t2qpg) - lansoprazole delayed-release orally disintegrating tablets are indicated in adults for short-term treatment (for four weeks) for healing and symptom relief of active duodenal ulcer [see clinical studies (14.1)] . triple therapy: lansoprazole delayed-release orally disintegrating tablets/amoxicillin/clarithromycin lansoprazole delayed-release orally disintegrating tablets in combination with amoxicillin plus clarithromycin as triple therapy is indicated in adults for the treatment of patients with h. pylori infection and duodenal ulcer disease (active or one year history of a duodenal ulcer) to eradicate h. pylori . eradication of h. pylori has been shown to reduce the risk of duodenal ulcer recurrence [see clinical studies (14.2)] . please refer to the full prescribing information for amoxicillin and clarithromycin. dual therapy: lansoprazole delayed-release orally disintegrating tablets/amoxicillin lansoprazole delayed-release orally disintegrating tablets in combination with amoxicillin as dual therapy is

United States - English - NLM (National Library of Medicine)

northstar rx llc - lansoprazole (unii: 0k5c5t2qpg) (lansoprazole - unii:0k5c5t2qpg) - lansoprazole delayed-release orally disintegrating tablets are indicated in adults for short-term treatment (for four weeks) for healing and symptom relief of active duodenal ulcer [see clinical studies (14.1) ]. triple therapy: lansoprazole delayed-release orally disintegrating tablets/amoxicillin/clarithromycin lansoprazole delayed-release orally disintegrating tablets in combination with amoxicillin plus clarithromycin as triple therapy is indicated in adults for the treatment of patients with h. pylori infection and duodenal ulcer disease (active or one year history of a duodenal ulcer) to eradicate h. pylori . eradication of h. pylori has been shown to reduce the risk of duodenal ulcer recurrence [see clinical studies (14.2) ]. please refer to the full prescribing information for amoxicillin and clarithromycin. dual therapy: lansoprazole delayed-release orally disintegrating tablets/amoxicillin  lansoprazole delayed-release orally disintegrating tablets in combination with amoxicillin as dual thera

United States - English - NLM (National Library of Medicine)

rally labs llc - aspirin 500 mg (nsaid*) caffeine 60 mg *nonsteroidal anti-inflammatory drug - aspirin…..pain reliever caffeine…alertness aid/pain reliever aid - for the temporary relief of minor aches and pains associated with a hangover - helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness associated with a hangover - also for the temporary relief of headaches or body aches and pains alone - for the temporary relief of headache pain - also temporarily relieves minor aches and pains due to: backache muscle aches arthritis menstrual cramps hangover - for the temporary relief of muscle aches and pain - helps restore mental alertness when experiencing fatigue - if you have ever had an allergic reaction to aspirin or any other pain reliever/fever inducer - stomach bleeding warning applies to you - you have a history of stomach problems, such as heartburn - you have high blood pressure, heart disease, liver cirrhosis, or kidney disease - you are taking a diuretic - you have asthma - you have a sodium-restricted diet taking a prescription drug for - diabetes - gout - arthritis arthritis - an allergic reaction occurs. seek medical help right away. - you experience any of the following signs of stomach bleeding: feel faint vomit blood have bloody or black stools have stomach pain that does not get better  you experience any of the following signs of stomach bleeding: - feel faint - vomit blood - have bloody or black stools - have stomach pain that does not get better  - pain lasts for more than 10 days or gets worse pain lasts for more than 10 days or gets worse - new symptoms occur new symptoms occur - redness or swelling is present redness or swelling is present - ringing in the ears or a loss of hearing occurs ringing in the ears or a loss of hearing occurs

Australia - English - Department of Health (Therapeutic Goods Administration)

naturally no more nits - azadirachta indica,cedrus deodara,melaleuca oil -

Australia - English - Department of Health (Therapeutic Goods Administration)

naturally no more nits - azadirachta indica,cedrus deodara,melaleuca oil -

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron, quantity: 8 mg - tablet, orally disintegrating - excipient ingredients: magnesium stearate; microcrystalline cellulose; guar gum; crospovidone; sodium lauryl sulfate; colloidal anhydrous silica; mannitol; aspartame; pregelatinised maize starch; flavour - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron, quantity: 4 mg - tablet, orally disintegrating - excipient ingredients: crospovidone; magnesium stearate; sodium lauryl sulfate; mannitol; colloidal anhydrous silica; pregelatinised maize starch; microcrystalline cellulose; aspartame; guar gum; flavour - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron, quantity: 8 mg - tablet, orally disintegrating - excipient ingredients: crospovidone; magnesium stearate; aspartame; guar gum; colloidal anhydrous silica; sodium lauryl sulfate; microcrystalline cellulose; mannitol; pregelatinised maize starch; flavour - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron, quantity: 4 mg - tablet, orally disintegrating - excipient ingredients: aspartame; microcrystalline cellulose; guar gum; crospovidone; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate; mannitol; sodium lauryl sulfate; flavour - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron, quantity: 8 mg - tablet, orally disintegrating - excipient ingredients: magnesium stearate; microcrystalline cellulose; guar gum; crospovidone; sodium lauryl sulfate; colloidal anhydrous silica; mannitol; aspartame; pregelatinised maize starch; flavour - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.